A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Clinical trial NCT07304154 · RECRUITING

Trial details

NCT number: NCT07304154
Sponsor: Kite, A Gilead Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy Myasthenia Gravis Multiple Sclerosis

Start date: 2026-04-10
Primary completion: 2029-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.